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HLAWe studied viral evolution in three HIV-1 ancestral patients from a group of LTNPs; although some minor
sequences showing viral evolution were detected in all patients, the extremely low viral evolution of their
viruses was shown by the phylogenetic analysis of the env sequences. Complete nucleotide sequencing of
viral DNA showed the major presence of deletions. In two patients, deletions of 1088 and 228 nucleotides
mapped to 5′ LTR–gag region; in the other, a 247 nucleotide deletion was positioned in pol gene up to the vif
ORF. These deleted genomes became dominant during follow up. Patient's viruses displayed 13 common
mutations in conserved residues, from the 5′ LTR to the nef gene. These mutations provided evidence of a
common origin. Regarding host characteristics, one patient had HLA B2705/B5801; another B1402/B5701;
whereas a third showed B3901/B4402 and was Δ32-CCR5 heterozygous. These HIV controllers presented a
combination of deleted viral genomes and host protective factors.© 2009 Elsevier Inc. All rights reserved.IntroductionIndividuals achieving stricter control of viral replication among
long-term non-progressor patients (LTNP) (Buchbinder et al., 1994;
Keet et al., 1994; Learmont et al., 1992; Lifson et al., 1991; Sheppard
et al., 1993) are designated HIV controllers, elite suppressors, or elite
controllers (Bailey et al., 2006; Blankson et al., 2007; and Saez-Cirion
et al., 2007). We deﬁned a group of ancestral LTNPs showing only
ancestral nucleotide sequences, i.e. sequences close in dating time to
seroconversion (Bello et al., 2005) with a viral dating methodology
(Bello et al., 2004) based on the analysis of nucleotide sequences.
Similarly, another group of LTNPs, referred to as modern, displayed
modern viral dating: i.e. sequence time estimation close to the
sampling date (Bello et al., 2005). In the ancestral group, the viral
dating resulted from the absence of viral evolution since primary-
infection; whereas in the modern subset, the classiﬁcation was
determined as a consequence of continuous viral replication (Bello
et al., 2005). Because the HIV patients of the study–who display the
ancestral viruses–fulﬁll all the criteria for HIV controllers or elite
controllers, these distinct categories of HIV controllers or elitell rights reserved.controllers and ancestral LTNPs should be considered equivalent.
Similarly, patients with modern viruses are also equivalent to clinical
LTNPs.
The control of viral replication in LTNPs has been associated with
various host, immune, and viral factors. Regarding host characteristics,
certain HLA alleles, particularly HLA B⁎27 and B⁎57, have been found
to be overrepresented in LTNPs (Migueles et al., 2000). Other genetic
markers, such as the heterozygous Δ32 CCR5 genotype have been
related to a longer clinical evolution and control of viral replication
(Stewart et al., 1997; Wu et al., 1997a). Other polymorphisms in CCR2,
CCL3L1 and CCR5 have been associated with LTNPs (Gonzalez et al.,
2001; Gonzalez et al., 2005).
From a virological point of view, important deletions and
deleterious mutations have been found predominantly in the nef
gene (Deacon et al., 1995; Kirchhoff et al., 1995) but also in tat, rev, vif,
and env genes of viruses from LTNPs (Alexander et al., 2000; Calugi
et al., 2006; Farrow et al., 2005; Wu et al., 1997b). Viral mutations
occurring in the complete genome of one LTNP were reported (Wang
et al., 2003); in the replicating viruses of four Elite controllers
(Blankson et al., 2007); in a transmitted pair (Bailey et al., 2008); in
one Italian patient (Calugi et al., 2006); and recently in 17 elite
controllers LTNPs from a Boston cohort (Miura et al., 2008).
We studied viral evolution in three HIV-1 ancestral LTNPs with
extremely low viral evolution. During follow up of these patients, we
74 V. Sandonís et al. / Virology 391 (2009) 73–82estimated the genetic variation of the viral quasispecies in the env
gene, and these datawere correlated with clinical, immunological and
host markers. Finally, we determined the complete nucleotide
sequence of the viral DNA from the three patients in whom we
detected, as common characteristics, the major presence of deleted
forms and 13 unusual mutations in the viral genome.Results
Clinical, virological, immunological and host characteristics of
the patients
Viral evolution was studied in viruses from three HIV-1 LTNPs
(patients 3, 20 and 56) with an extreme control of their viral
replication. For these viruses, the time estimation of the nucleotide
sequence or “viral dating” was ancestral—close to the seroconversion
time (Table 1) (Bello et al., 2005). Plasma viral load in those patients,
except for independent blips below 2000 cp/ml, was below the
detection limit (b50 copies/ml) (Table 1 and Fig. 1). DNA copies per
million cells were estimated close to 2 copies in patients 3 and 56 and
at a mean of 55 in patient 20 (Table 1). These characteristics show that
these patients could also be considered HIV controllers or Elite
controllers (Blankson et al., 2007; Pereyra et al., 2008). The viruses
from these ancestral patients were compared with those of two LTNPs
(patients 7 and 30) infected for the same period of time, but
displaying viruses with “modern dating” (Table 1). The viral load of
modern patients was below 2000 copies in patient 7; above this
threshold in patient 30, and the mean DNA load was 14.3 and 46.8
copies/106 PBMC respectively. The co-culture of the patient PBMCs,
performed in one or two samples per patient, was negative in all the
ancestral patients but positive for those with a modern dating. The
same co-culture method (see Materials and methods) was positive inTable 1
Virological data of the patients.
Patient Sampling date
(month/year)
Serocon /yeara Viral Datingb H
(c
LTNP3 02/03 b1988 1986
10/03 1986
04/04 1986
01/05 1986
Mean
LTNP 20 10/04 1988 1988
06/05 1988
04/06 1988
Mean
LTNP56 06/98 b1989 1987
02/99 1987
02/00 1987
07/01 1987
04/02 1987
11/04 1987
06/05 1987
Mean
LTNP7 09/02 1987 2001
09/04
03/05
Mean
LTNP30 01/98 b1989
12/98 2000 5
04/00 1
09/01
04/02
09/02 1
04/04 4
Mean 1
a Estimation of the seroconversion year.
b Viral dating estimated according to Bello et al. (2004).
c Heterogeneity is themean nucleotide genetic distance as a percentage between all pair-w
d Divergence is the mean nucleotide genetic distance as a percentage of all pair-wise comonly one of another 8 ancestral LTNPs but in 6 out of 8 with modern
dating (data not shown).
Regarding immunological characteristics, ancestral patients (3, 20
and 56) presented normal values of CD4+, CD8+ cells and β-2
microglobulin. In the two modern LTNPs patients (30 and 7) their
values were very different for all markers, including a CD4+/CD8+
inverted ratio b1 (see Fig. 1 and Table 2).
In relation to host characteristics, patient 3 showed the protective
HLAs B2705/B5801 alleles, patient 56 the B5701, whereas patient 20
showed the B4402 allele together with the protective CCR5 Δ32
genotype (Table 2). Modern LTNP 7 showed the protective HLA A2601
and B4403 alleles and it was Δ32 heterozygous, while patient 30
displayed the A2601 haplotype. The analysis of all these virological,
immnunological and host markers support the drastic differences
between HIV-1 ancestral patients and the modern LTNPs.Phylogenetic analysis of the patient viral quasispecies
Viral evolution was analyzed in the viral DNA from the patients
PBMC. Patient viral nucleotide sequences, in the C2–V5 region of env
gene, were obtained from 6 to 28 nested PCR products per sample
performed at limiting dilution. Each patient studied displayed all its
viral sequences in one cluster of a general tree (data not shown). In the
viruses from the HIV ancestral patients 3, 20 and 56, the Maximum
Likelihood (ML) phylogenetic trees showed extremely short branch
length (Fig. 2) and consequently an extremely low viral evolution
from their MRCA (Most Recent Common Ancestor), in spite of the
ancestral patients having been infected for more than 18 years. The
genetic heterogeneity obtained in each sample was extremely low
(with mean values below 1%) (Table 1). In addition, all viral
divergence values were always below 1.5% and moreover they did
not increase with time (Table 1).IV-1 RNA
opies/ml)
HIV-1 DNA
(copies/106PBMCs)
Heterogeneityc Divergenced
b50 1.0 0.70±0.18 1.27±0.43
b50 1.6 0.42±0.19 1.00±0.63
b50 1.2 0.29±0.16 1.31±0.48
b50 4.3 1.27±0.31 1.36±0.41
2.0 0.67 1.23
51 75.6 0.59±0.16 1.32±0.50
b50 29.8 0.52±0.14 1.29±0.50
68 59.6 0.01±0.00 1.12±0.50
55 0.37 1.24
627 1.2 0.53±0.17 0.72±0.30
1762 1.6 0.47±0.14 0.44±0.19
b50 2.2 0.08±0.08 0.23±0.18
300 ND 0.34±0.12 0.54±0.26
109 1.3 0.23±0.14 0.42±0.24
b50 2.6 0.90±0.25 1.87±0.54
b50 3.4 0.15±0.10 0.28±0.19
1.9 0.39 0.64
672 13 5.83±0.27 4.78±0.74
681 13 8.74±0.50 6.15±0.12
818 17 11.33±0.34 9.55±1.36
724 14.3 8.63 6.83
4973 18 9.27±0.45 6.99±0.67
062 7 11.09±0.55 8.65±0.83
7567 64 11.26±0.43 10.03±1.10
2518 16 5.00±0.38 13.95±0.32
5890 31 5.57±0.35 14.68±0.26
5381 76 7.65±0.40 13.86±0.16
6819 116 11.15±0.46 13.29±1.05
4030 46.8 8.71 11.63
ise comparisons of sequences from each time point±SEM (SeeMaterials andmethods).
parisons of sequences to the MRCA±SEM. (See Materials and methods).
Fig.1. Plasma RNAviral load and CD4+ Tcell values over time in the patients studied. Each graph represents plasma viral load and CD4+ T numbers as a function of time. Plasma RNA
viral loads (copies/ml) are shown by solid black circles on the left vertical axis and are joined by a solid line. Empty circles represent viral loads determined by the Amplicor HIV
Monitor test with a detection limit of 500 copies/ml. For samples with an RNA viral load below the detection limit (50 cp/ml), we assigned a value of 50 cp/ml. Numbers of CD4+T
cell counts are depicted on the right vertical axis and marked by solid black triangles and joined by a dotted line. Arrows indicate the samples in which viral quasispecies were
analyzed. In A) are shown the graphs of LTNPs 3, 20 and 56 displaying ancestral viruses; whereas B) display the values of LTNPs 7 and 30 with modern viruses.
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modern LTNPs (patient 7 and 30) showed a progressive increase in the
divergence from the MRCA (from 4.78 to 9.55% in 3 years and from
6.99 to 14.68% in 6 years respectively) as can be seen by the longer
branches in the phylogenetic trees (Fig. 2B). Viruses from modern
patients also showed much higher heterogeneity values (from 5.83 to
11.33%) in patient 7 and (from 9.27 to 11.15%) in patient 30.
In addition, in every HIV ancestral patient, we found, however,
minority sequences (encircled in the trees of Fig. 2A) showing longer
genetic distances to the MRCA. These sequences displaying more
evolution were observed in one sequence of patient 3 (1.8%), in 2
sequences (2.6%) of patient 20 and in 10 sequences (11%) of patient
56. In patient 3, the evolved sequence (3.5.59) diverged by a mean of
5.6% to the MRCA. In patient 20, sequences (20.1.36 and 20.2.7)
obtained in different years-showed a 5.8% genetic distance to the
MRCA. In patient 56, 10 sequences of sample 11/04 showed a meandivergence of 2.4%. In spite of the presence of these minority evolved
sequences, all virological data studied showed that viral populations
within this subset of HIV ancestral LTNPs have remained highly
homogeneous and have not diverged from the infecting viral
populations.Complete nucleotide sequencing
To analyze if the absence of viral evolution observed in the patients
with ancestral dating was a consequence of defects in the viruses,
complete nucleotide sequencing from viral DNA was undertaken. A
complete consensus sequence from sample 01/05 of patient 3, sample
10/04 from patient 20 and sample 11/04 from patient 56 (Table 4),
achieved with the BioEdit program and derived from at least three
different ampliﬁcations, was derived from three fragments covering
Table 2
Immunological and genetic characteristics of the patients.
Patient Sampling year CD4+ cells/μl %CD4+ CD8+cells/μl %CD8+ Ratio β-2 μg/ml CCR5 HLA-A HLA-B
LTNP 3 02/03 800 43.5 535 29 1.5 1.7
10/03 819 42.9 600 31 1.4 +/+ A0201/A0205 B2705/B5801a
04/04 823 44.7 567 31 1.5
01/05 880 43.8 604 30 1.5 2.2
Mean 830 44 576 30 1.5
LTNP 20 10/04 894 43 740 36 1.2 +/Δ32 A0201/A2902 B3901/B4402b
06/05 855 43 697 35 1.2 2.48
04/06 855 40 885 40 1.0
Mean 868 42 774 37 1.1
LTNP 56 06/98 1034 49 507 24 2
02/99 969 54 434 24 2.2 1.1. +/+ A0101/A0201 B1402/B5701
02/00 946 46 571 28 1.7
07/01 824 50 422 26 2
04/02 974 45 557 26 1.7
11/04 938 50 437 23 2.1
06/05 906 48 466 25 1.9 2.1
Mean 941 49 485 25 1.9
LTNP 7 09/02 603 15 2718 66 0.2 2.7 +/Δ32 A2601/A2902 B4403/B4901
09/04 570 15 2073 71 0.2
03/05 571 15 3212 74 0.2
Mean 581 15 2668 70 0.2
LTNP 30 01/98 930 36 1058 41 0.3 3.8 +/+ A1101/A2601 B1501/B3501c
12/98 723 35 869 43 0.8
04/00 812 35 1016 44 0.8
09/01 933 33 1263 44 0.7
04/02 937 32 1271 44 0.7
09/02 858 30 1218 42 0.7
04/04 691 31 1001 45 0.7
Mean 840 33 1099 43 0.6
All these effects as in (Altfeld et al., 2006).
a Bold font indicate a strong protective HLA and Δ32 protective alleles.
b Underlined haplotypes are genotypes with a milder protective effect.
c HLA in italics are associated with AIDS progression.
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sequence is shown in Fig. 1 of supplementary material.
The most important and common characteristic found in ancestral
patient's viral DNA was the major presence of deletions in the
genomes. These deletions were dominant in patient's quasispecies
(Table 3). The 247 nucleotides deletion in patient 3 was localized in
pol gene from nucleotide 4865, corresponding to amino-acid 928 in
integrase, until amino-acid 23 in vif protein (Fig. 3). This deletion
maintained the open reading frame between integrase and vif protein
that could result in a fusion protein. In patients 20 and 56, the
deletions mapped in the 5′ LTR (Fig. 3). In patient 20, the major
deletion was of 1088 nucleotides (43% of the quasispecies) although
four other deleted genomes in the same region of 533 nucleotides
(present in 15%) and of 967, 501 and 134 nucleotides were detected
(each present in 7% in the viral population and not shown in Fig. 3).
Patient 56 showed a major deletion of 228 nucleotides (37%) but also
another of 120 nucleotides present in 18% in the viral population (Fig.
3). Genomic analysis of the same LTR–gag region, in 4 other ancestral
patients (with similar viral and clinical evolution), in 5 modern LTNPs
and in 4 regular progressors (Table 3) was performed. This analysis
showed that, although some deletions were observed in other LTNPs
(ancestral and modern) and in regular progressor, the presence of
deleted genomes was higher in the viruses from the ancestral patients
of our study and its frequency decreased until the regular patient
group (Table 3).
In order to evaluate the importance of these deleted DNA viral
forms, we quantiﬁed their presence in the viral quasispecies in at leastFig. 2.Maximum likelihood phylogenetic trees of patients viral sequences in env gene. Partial
56 in (A) and modern LTNP 30 and 7 in (B). These late patients were used as controls of
represented along with Spanish reference strain S61 and LAI as outgroups. Sequences are rep
key. Numbers at branch nodes refer to the booststrap support (only values greater than 60
Branch lengths are drawn to scale, but scale in patients 3, 20 and 56 (0.01) is double than i3 samples from each patient. During the follow up, the deleted forms
were or became dominant in the DNA quasispecies of all patients. In
patient 3, the complete sequence was present at 100% in the ﬁrst
sample (02/03) studied and it was completely substituted by the
deleted from in the last sample (01/05) (Table 4). Patient 20 showed,
during follow up, the constant frequency of the deleted form at around
75% of the quasispecies (Table 4). Patient 56 showed an increase in the
proportion of the deleted form from 33% in the ﬁrst sample (04/02) to
75% in the last one analyzed (06/05) (Table 4). These results illustrate
the dominance and imposition of the deleted forms in the ancestral
patients.
Analysis of the mutations occurring in complete genomes
Apart from the major deletions observed in the LTR and integrase
region in pol gene, analysis of the complete viral nucleotide sequence
showed no minor deletions or insertions in the genomes resulting in
non-functional proteins as in other studies (Blankson et al., 2007;
Wang et al., 2002; Miura et al., 2008). In order to look for a possible
role for suboptimal mutations in viral genotype (Alexander et al.,
2001), we analyzed the sequences for infrequent changes. Accord-
ingly, we observed 94 positions altered in at least two viruses, in
comparison with the consensus subtype B sequence from the Los
Alamos data base (LANL) due to a lack of complete genome sequences
from Spanish samples. Fifty ﬁve alterations were mutated in the three
viruses studied. In order to analyze their importance, we selected
changes that occurred in conserved positions (those residues presentgp120 env sequences derived from PBMC DNA, at limiting dilution, of patients 3, 20 and
patients with the same infection time but showing evolution. Phylogenetic trees are
resented with arbitrary symbols corresponding to the sampling year, as explained in the
% are shown). Evolved sequences in HIV controllers are included within circular lines.
n patients 7 and 30 (0.02).
77V. Sandonís et al. / Virology 391 (2009) 73–82
Table 3
Quantiﬁcation of the deleted genomes in the LTR–gag fragment and pol–vif ORF in the virus from different groups of patients.
Patients 5′ LTR–gag region pol–vif ORF region
PCR+/PCR
performed
Complete
sequence
Δ Sequence PCR+/PCR
performed
Complete
sequence
Δ Sequence
No. % No. %
Ancestral patients
LTNP-3 6+/12 6 0 0 5+/19 0 5 100
LTNP-20 28+/129 6 22 78.5 5+/11 5 0 0
LTNP 56 16+/70 7 9 56 7+/23 7 0 0
Other ancestrala
LTNP-2 11+/25 7 4 36 4+/14 4 0 0
AS-7 10+/25 10 0 0 4+/4 4 0 0
LTNP-1 5+/7 4 1 20 4+/40 4 0 0
LTNP-5 9+/34 9 0 0 3+/19 3 0 0
Modern LTNPb
LTNP-7 11+/18 10 1 9 – – – –
LTNP-14 5+/16 4 1 20 – – – –
LTNP-16 6+/16 6 0 0 – – – –
LTNP-19 6+/16 6 0 0 – – – –
LTNP-30 9+/18 8 1 11 – – – –
Regular progressorsc
R-8 11+/15 9 2 18 – – – –
R-20 6+/15 6 0 0 – – – –
R-32 7+/15 7 0 0 – – – –
R-33 6+/15 6 0 0 – – – –
a Other LTNP with an ancestral dating under study in our laboratory.
b LTNP with a modern viral dating.
c HIV infected patients with a regular infection.
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base), and also considered that the mutated residue was not frequent
in the data base (b15% in subtype B nucleotide sequences) as inFig. 3. Schematic representation of the major deletions forms found in the patients studied.
depict the major deleted form with the nucleotide numbers (starting at the beginning of th
represent functional motifs in the leader sequence such as the t-RNA PBS, the dimerization (D
the deletion are shown in nucleotides and in amino acids. Percentages on the right column(Alexander et al., 2001). This analysis disclosed 11 residues and 2
nucleotide positions in the 5′ LTR which are summarized in Table 5.
Among these changes, we identiﬁed mutation G123R in p17 gagIn each patient, the upper line correspond the complete wt genome and the lines below
e U3 sequence) before and after the deletions. In patients 20 and 56, the hatched boxes
IS), the splice donor (SD) and the ψ signals loops (not to scale). In patient 3, the limits of
correspond to the absolute percentage of each genomic form in the quasispecie.
Table 4
Quantiﬁcation of the major deleted DNA forms in the samples analyzed in each patient.
LTNP 3
Sampling datea 02/03 10/03 01/05#
Complete genome 100%⁎ 55%⁎ 0%
Deleted genome 0% 45% 100%
LTNP 20
Sampling datea 10/04# 06/05 04/06
Complete genome 21% 23.5% 24%
Deleted genome 79% 76.5% 76%
LTNP 56
Sampling datea 04/02 11/04# 06/05
Complete genome 66% 44% 25%
Deleted genome 33% 56% 75%
aSampling time like in Table 1. Quantiﬁcation of the different DNA forms has been made
by clonal analysis at limiting dilution PCRs.⁎Quantiﬁcation performed by acrylamide gel
band analysis. # Samples submitted to complete genome analysis.
Table 5
Analysis of infrequent mutations found in common in the complete genome of the
patients studied compared to the LANL data base sequences.
Gene Positiona Consensus B Patients Acceptabilityc
NUC AA %b Mutation %b
5′ LTR 68 C 95 A 0
453 T 93 G 5
A 2
GAG P17 123 G 79 R 1 3
P2 372 N 72 S 8 5
G 5 3
P1 441 H 79 Y 6 3
POL 9 P 81 L 14 3
55 S 76 G 5 5
VIF 130 S 81 I 3 2
VPU 77 D 82 V 5 3
ENV
gp120 292 V 91 I 8 5
353 F 87 L 2 4
Y 9 5
gp41 756 I 80 F 12 4
NEF 12 G 87 R 1 3
a Numbering as in the LANL data base.
b Percentage of the presence of this nucleotide or amino-acid in the LANL data base.
c According to (Feng, Johnson, and Doolittle, 1985), where 6 indicates changes by the
same amino-acid and 1 changes with the strongest alteration.
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protein. We also detected mutations N372S/G, in the middle of p2, as
well as mutation H441Y in the middle of p1. These three mutations
were close to proteolytic cleavage sites. The last two mutations were
also found in a set of replicating virus in a group of American elite
controllers (Blankson et al., 2007). Mutations in gp120 were mapped
in the external part of the protein. Among these 11 common changes,
9 represented strong alterations (level 3 or 4) according to Feng et al.
(1985) (Table 5).
Discussion
Our study of the virological, clinical and immunological character-
istics in three HIV ancestral LTNPs showed extremely low viral
evolution a result that was deduced from the genetic variation values
(Table 1) and the phylogenetic trees (Fig. 2). The complete genome
sequencing of viral DNA, from these patients, showed the major
presence (from 56 to 100%) of genomes with deletions as the
dominant form. In addition, HIV ancestral patients presented several
host protective markers such as HLA B2701, B5701; B5801; or the
B4402; and Δ32-CCR5 genotype. Although differences were evident
among the patients, the control of viral replication seems to be
achieved by various combinations of virological and host protective
factors (Deeks and Walker, 2007).
These results contrast with those obtained by analyzing modern
LTNPs patients infected for the same time duration but displaying
signs of viral evolution. In these patients, all these virological markers
were different (Table 1, Figs. 1 and 2). In addition, deleted genomes
were present at a lower proportion (Table 3). In this study we have
used the classiﬁcation of ancestral and modern LTNPs based on the
existence of viral evolution. Our patients fulﬁlled the criteria of Elite
controllers or HIV controllers: more than 10 years of infection:
b50 cp/ml viral load and blips of less than 2000 copies/ml. Although
these categories account for different markers, these ancestral
patients are equivalent to the HIV controllers or elite controllers.
Although there is a strict control of viral replication in ancestral
patients, multiple evidence showed the occurrence of occasional and
constrained viral replication. Viral replication was deduced, for
example, by the presence of longer branches in the phylogenetic
trees. These sequences were present occasionally and in minor
proportion (from 11% to 1.8%) in the quasispecies (Fig. 2 and Table 3),
and they cannot be considered to have come from a super or co-
infection because they shared, with a high bootstrap value, the same
MRCA with the other sequences of each patient (see Fig. 2). These
evolved sequences probably represent replicating viruses, and they
could correspond to the replicating viruses obtained in another study
with 4 elite controllers (Blankson et al., 2007) or the viruses responsible
for the persistent viremia in another study (Hatano et al., 2009).
The complete genome analysis disclosed that the three viruses
from the ancestral patients presented important deletions. For theﬁrst time in LTNPs, two of the viruses mapped the deletions in the 5′
LTR (Visco-Comandini et al., 1999). It is probable that the detection in
this region is related to the strategy and position of the primers used
for the complete genome sequencing (Miura et al., 2008). To test that
these deletions were not a PCR artifact, we ampliﬁed the 5′ LTR region
in these same patients with different primers and with Taq
polymerase instead of the Expand High Fidelity for whichwe obtained
the same deletions. We also performed the same comparison in the
integrase region in pol gene in patient 3 that resulted in an identical
deletion. In addition, when analyzing patients with a similar infection
time, we found fewer deletions in the 5′ LTR region in 9 other LTNPs: 4
ancestral patients (36% to 0%) and 5 modern LTNPs (20 to 0%). Lower
percentages were found in 4 regular progressors (18 to 0%) (Table 3).
In addition, the presence of deletions in viral quasispecies from
regular progressors has been previously described in the env gene
(Meyerhans et al., 1989) or in other genes (Li et al., 1991).
Deletions in patients 20 and 56 included important motifs for viral
replication in the leader sequence, such as the PBS, DIS, SD, and Ψ
loops or the lack of p17 in patient 20 (Fig. 3). These deletions make the
replication of these viruses unlikely. In addition, the viral deletion in
virus from patient 3 maintained the open reading frame between
integrase and vif protein.
Both the presence of these deleted viruses and their contribution
to the pathology of the infection are still not clear. However the minor
presence of deletions from the ancestral to the modern LTNPs group
(up to 20%) and their low presence (18%) or absence in regular
progressor patients could indicate their importance in HIV pathogen-
esis (see Table 3). Our ancestral patients showed low DNA viral loads;
close to 55 copies per million PBMCs cells in patient 20 or extremely
low, close to 2 cells per million PBMCs in patient 3 and 56. Upon
activation of these reservoir cells, these deleted viral forms will be
transcribed because of their dominance in the quasispecies (from 56%
to 100%). However, they will lead to defective or at least less efﬁcient
virus. In contrast, the replication of the complete virus will be minor
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these deleted forms could contribute to the control of viral replication
of the complete virus by an interfering mechanism as previously
demonstrated in HIV-1 (Guan et al., 2001; Huang and Baltimore,1970;
Trono, Feinberg, and Baltimore, 1989). On the other hand, the major
presence of these deleted forms in viral quasispecies could be the
consequence of the elimination, by the immune system at the time of
primo infection (Wang et al., 2002), of the cells harboring the
complete replicating forms. Perhaps, these deleted genomes could
also be generated upon replication of the complete virus by a variant
reverse transcriptase or because of structural motifs (such as loops or
hairpins) in the deleted regions like in the U5 in the LTR.
Analysis of the common but unusual mutations (infrequent amino
acids or nucleotide in conserved residues, Table 5) in the three
patients did not indicate a clear defective phenotype. These mutations
did not suppose premature stop codons, altered catalytic sites or
important changes in the structural motifs of viral proteins as shown
in other studies (Blankson et al., 2007; Miura et al., 2008). The
presence of these unusual mutations or “signature” alterations in
other Spanish samples is unknown because only one complete
genome sequence is available in the LANL data base and also because
few partial nucleotide sequences from Spain are present in these data
bases. Taking into account that the deleterious phenotype could be
conferred by a combination of suboptimal mutations (Alexander et al.,
2001), the replicative characteristics conferred by the different
mutations in single and multiple combinations are under investiga-
tion. A recent study has found only three mutations in the gag gene
(67A, 102E and 389I) with an statistical signiﬁcance, associated with
HIV elite controllers (Miura et al., 2008). Although these mutations
did not appeared in Table 3 due to the selection criteria, however,
patients 3 and 20 showed the 67A and patients 3, 20 and 56 the 102E
and 389I in gag gene.
The presence of a high number of common mutations in all three
patient's viruses indicates a common origin as the consequence of a
founder effect. All the nucleotide sequences from these viruses were,
however, always segregated (by different phylogenetic analysis), in
different branches of phylogenetic trees performed with Spanish
samples (Casado et al. manuscript in preparation). This common
origin of the viruses is in contrast with previous studies where a
common origin was not found in HIV controllers or elite controllers
(Blankson et al., 2007; Miura et al., 2008).
Many host factors have been associated with patients having a non
progressive HIV-1 infection. The strongest associationwas found with
certain HLA allelles and indeed patients 3 and 56 displayed the B2705,
the B5801 and B5701 alleles respectively (Migueles et al., 2000).
Patient 20 had the B4402 protective haplotype and the B3901 HLA
allele included in the B⁎27 supertype family that also conferred
protective characteristics. Moreover, this later patient was also
heterozygous for the Δ32 CCR5 receptor related to a delayed clinical
progression (Stewart et al., 1997). Then the HIV-1 controller patients
studied showed at least one, and even two host markers related with
non progression.
In the viruses from three HIV ancestral patients we have identiﬁed
a very limited viral evolution, important deletions and a possible
common phylogenetic origin. In addition, these ancestral patients
showed important host protective alleles. In summary, control of viral
replication in three ancestral patients was achieved by different
combinations of virological and host protective factors.
Materials and methods
Study subjects
We analyzed three patients (3, 20 and 56) from the Centro
Sanitario Sandoval (IMSALUD) who fulﬁlled the LTNPs criteria:
infected for more than 18 years but also with extreme control ofviral replication. Patients 3, 20 and 56 are considered ancestral
because the viral dating of the resident nucleotide sequence of the
virus was estimated to be close to their seroconversion time (Bello et
al., 2004).We compared these patients to control modern LTNPs
patients (7 and 30) that were infected for the same duration. Plasma
RNA viral load, except for blips in patient 56 and 20, was b50 copies/
ml (or b500 copies in older samples). We analyzed three to six
samples for each patient obtained from 9 to 19 years after
seroconversion and over a period of two to eight years. Patients 3,
56, 7 and 30 have been included in previous studies (Bello et al., 2005,
2007b). Other control patients in the ancestral (LTNP-2, AS-7, LTNP-1
and LTNP-5) and in modern LTNP group (LTNP-14, 16 and 19) and 4
patients with a regular progression (R-8, R-20, R-32 and R-33) were
also analyzed in the 5′ LTR and pol regions (Table 3).
Plasma HIV-1 RNA viral load was quantiﬁed with the Branched
DNA Siemens versant HIV RNA 3.0 assay (bDNA), with a detection
limit of 50 copies/ml. In the two initial samples from patient 2 and the
three initial samples from patient 56, the detection limit was 500
copies using the Amplicor HIV Monitor test kit, (Roche Diagnostics
Systems, Somerville, NJ).Virus isolation by co-culture of peripheral blood molecular cells (PBMC)
cells from patients
PBMC and plasma samples were obtained as described by (Casado
et al., 2001). 4.3×106 puriﬁed CD4+ T cells in patient 3.3×106 in
patient 20 and 6×106 in patient 56 were resuspended in RPMI 1640
(Bio-Whittaker) supplemented with 10% fetal bovine serum (Gibco)
plus 1% antibiotics (Bio-Whittaker) and Human Recombinant Inter-
leukin 2 (2.5 ng/ml, Sigma). They were co-cultured with 107 PBMC
from a healthy donor previously treated with Mitomicyn C (from
Streptomyces caespitosus, Sigma) for 30 min. The co-culture was
stimulated with 2 μg/ml phytohemaglutinin (PHA-Lectin, Sigma) and
incubated overnight at 37 °C. Next day, the co-culture was centrifuged
at 300 g for 10 min, the supernatant removed and 107 CD8+ depleted
PBMC, pre-stimulated for three days with PHA, were added. The
culture medium was changed twice a week and the co-cultures were
fed with 107 fresh pre-stimulated PBMC weekly. After 9 days of co-
culture, viral replicationwas estimated in the supernatant by an ELISA
to measure p24 antigen (Roche Diagnostic). Co-cultures were
maintained and tested for viral replication for one month, but always
with negative results in the HIV ancestral patients.
As a control of the co-culture technique, samples from a group of 8
modern LTNPs were assayed and 6 of the 8 co-cultures were positive,
including patients 7 and 30. Co-culture of PBMCs from 8 other
ancestral LTNPs patients was negative except for one sample in one
patient: this sample had a viral load of 125 RNA copies per ml. This
result could give an estimation of the sensitivity of the co-culture
technique.β2-microglobulin determination
Plasma β2-microglobulin concentrations were measured using an
ELISA (DRG Diagnostics) according to the manufacturer's instructions.
A control value of 1.02 μg was obtained using this kit in a set of 37
uninfected patients (Bello et al., 2005; Michael et al., 1997)).Characterization of the Δ-32 CCR5 genotype
Analysis of the Δ-32 CCR5 genotype was performed on PBMC DNA
by PCR as described by Michael et al. (1997). Primers ampliﬁed a gene
fragment of 225 nt for the wild-type allele and of 193 nt for the Δ-32
CCR5 allele, which were separated in 8% TBE polyacrylamide gel.
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PBMC-associated DNA was obtained from 107 cells by standard
phenol extraction methods. HIV DNA was ampliﬁed with different
primers from a single copy by limiting dilution PCR in the C2–V5
region in env gene as explained in (Bello et al., 2007a). PCR products in
the C2 to V5 region of the HIV env were sequenced with primer 27EU
(Bello et al. 2005) using the ABI PRISM Dye Terminator reaction kit
(Perkin-Elmer, Norwalk, Conn.) according to manufacturer's instruc-
tions in an ABI PRISM 377 automated sequencer. All PCRs ampliﬁca-
tions were done with procedural safeguards and physical separation
of sample processing and post-PCR handling steps in order to control
for cross-contamination. For PCR ampliﬁcation and to minimize the
introduction of non authentic mutations, we used Expand High
Fidelity polymerase (Roche).
Nucleotide sequence and phylogenetic analysis in env gene
Nucleotide sequences obtained by limiting dilution PCRs of the
614-bp C2–C5 fragment in env gene (nucleotides 7068 to 7682 in
HXB2 clone) were examined. Nucleotide sequences were initially
edited using the SeqMan program version 3.61 (Inc. Dnastar, Madison,
Wis) and aligned with program CLUSTAL X version 1.8. Alignments
were later corrected by hand to assure a correct open reading frame.
All positions with an alignment gap were excluded from the analysis.
First, nucleotide sequences were included in a global data base with
the sequences obtained from patients studied in our laboratory and a
phylogenetic tree was constructed to detect cross-contamination
between samples. All samples were segregated in distinct clusters of
the phylogenetic tree, then excluding contamination. For each patient,
best-ﬁt models of nucleotide substitution were selected according to
the Akaike Information Criterion (AIC) in Modeltest 3.6 (Posada and
Crandall, 2001). Maximum likelihood trees were constructed under
this best-ﬁt model using the algorithm implemented in Phyml v.2.4.1
(Guindon et al., 2005), starting the search from a BIONJ tree (Gascuel,
1997). Phylogenetic conﬁdence was assessed by bootstrap analysis of
1000 replicates.
Intrasample (heterogeneity) and intersample (divergence) genetic
distances within each patient were estimated by the best-ﬁt model of
nucleotide substitution. To estimate viral heterogeneity at a given
time point, we determined the mean and standard error for pair-wise
nucleotide distances between all sequences obtained at that time
point. To estimate viral divergence at a given time point, we
determined the mean and standard error for pair-wise nucleotide
distances between all sequences from that time point and the patient
most recent common ancestor sequence (MRCA). The MRCA for each
patient was obtained using the PAUP4.0b10 program from recon-
structed trees by the Maximum likelihood method. This MRCA
sequence represents the most distal node of the tree from which all
nucleotide sequences from the patient originate.
Viral dating
An estimation of viral infection time or “viral dating”was deduced,
assuming a molecular clock, from the genetic distance of the
nucleotide sequence of each patient virus to the MRCA of the HIV-1
Spanish epidemic according to (Bello et al., 2004) and (Bello et al.,
2005, 2007b).
PCR ampliﬁcation and sequencing of the complete genome
To perform the complete genome sequencing, the genome
(9250 bp) was divided into three fragments. In each fragment, from
three to 9 limiting dilution PCR were analyzed. We used nested PCRs
and Expand High Fidelity DNA polymerase (Roche) to amplify viral
DNA. Primer locatization and fragment ampliﬁcation are shown inTable 1 of the Supplementary materials. The ﬁrst PCR, ampliﬁed an
1807 bp fragment from the 5′ LTR to the gag region. The second PCR
encompassed a 3545 bp fragment in the pol–vif region. The third
comprised a 3906 bp fragment from vif gene until U5 at the 3′ end of
the HIV-1 genome.
Cycling conditions of the nested PCR for the ﬁrst fragment were the
following: one cycle of 94 °C for 5 min,10 cycles of 94 °C for 30 s, 55 °C
for 30 s and 72 °C for 2 min. Subsequently, 25 cycles of 94 °C for 30 s,
55 °C for 30 s, and 72 °C for 2 min with an extension of 5 s each cycle,
and a ﬁnal step of 72 °C for 10 min. For the second fragment, cycling
conditions were the same except that the annealing temperature was
60 °C and the length of the elongation step was 4 min. For the third
fragment, cycling conditions were the same as for the ﬁrst fragment
except for the length of the elongation step which was 4 min.
GenBank accession numbers of the viral nucleotide sequences of
the patients are pending.
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